BB Biotech’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
$67.4M Sell
2,377,638
-8,833
-0.4% -$250K 1.69% 20
2018
Q4
$71.9M Hold
2,386,471
2.3% 16
2018
Q3
$83.6M Sell
2,386,471
-97,600
-4% -$3.42M 2.21% 16
2018
Q2
$58.9M Buy
2,484,071
+94,500
+4% +$2.24M 1.7% 17
2018
Q1
$61.2M Buy
2,389,571
+1,140,921
+91% +$29.2M 1.69% 18
2017
Q4
$21.7M Buy
+1,248,650
New +$21.7M 0.61% 25